how does glp-1 stimulates insulin secretion Agonists: Increasing Effective Release GLP-1 Agonists Explained: The Future

Investigational cancer drugs targeting cell metabolism in clinical development

[PubMed: 19307519] 551

Glucagon-like peptide 1 (GLP-1) is a hormone that triggers the release of insulin, inhibits the secretion of glucagon to prevent blood sugar levels rising, slows the emptying of the stomach and increases satiety

By shortening the peptide chain IGF-1 becomes 10 times more potent in terms of increasing hypertrophy as well as reducing the binding of IGF-1 binding proteins due to the absence of glutamate

Each compound addresses distinct physiological challenges associated with metabolic optimization, and together they create a more comprehensive approach than either achieves independently